Summary & Overview
HCPCS G6058: Drug Confirmation, Single Procedure
HCPCS Level II code G6058 denotes a single-instance drug confirmation procedure used to verify the presence, identity, or concentration of a medication. Nationally, accurate coding for drug confirmation is important for clinical documentation, laboratory billing, and payer adjudication given the increasing emphasis on laboratory transparency and controlled-substance monitoring. This code applies to discrete confirmation assays rather than broad-panel screening.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of what G6058 represents clinically, typical sites of service, and common billing considerations tied to laboratory drug confirmation services. The publication outlines typical modifier usage and highlights areas where payers commonly require documentation or preauthorization workflows. It also provides benchmarking context and notes where input data is unavailable.
This summary equips billing managers, laboratory directors, and compliance teams with a clear, national-level reference for when to use HCPCS Level II code G6058, what to expect from major payers, and which operational details are most relevant for correct claim submission and adjudication.
Billing Code Overview
HCPCS Level II code G6058 is defined as Drug confirmation, each procedure. This code represents a billable service for performing an assay or test used to confirm the presence, identity, or concentration of a medication for a single procedure or encounter.
-
Service type: Drug confirmation testing
-
Typical site of service: Clinical laboratory or outpatient facility where specimen collection and laboratory testing occur
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult receiving outpatient infusion or medication administration in a hospital outpatient infusion center, ambulatory infusion clinic, oncology clinic, or emergency department. The clinician orders a drug confirmation test to verify the identity, concentration, or presence of the administered medication (for example, confirming monoclonal antibody drug levels or presence of a specific biologic agent) prior to or after infusion when documentation of drug presence is required for safety, therapeutic monitoring, or payer verification. The clinical workflow includes: pre-procedure medication verification and consent, specimen collection (blood or other biological sample) or device swab, transport to the clinical laboratory, performance of the drug confirmation assay, result reporting into the electronic medical record, and documentation of the test in the patient chart. The billing staff appends modifier TC when only the technical component of the drug confirmation procedure is billed by the facility; the professional component may be billed separately if applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
TC | Technical component | Use when billing the facility for the technical portion of the drug confirmation procedure (equipment, supplies, and technician time). |